Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities


Creative Commons License

KARKUCAK M., ÇAPKIN E., Cakirbay H., Akyuz A., ALVER A., CANSU A., ...More

TURKISH JOURNAL OF RHEUMATOLOGY, vol.26, no.3, pp.204-209, 2011 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.5606/tjr.2011.032
  • Journal Name: TURKISH JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.204-209
  • Keywords: Anti-citrullinated protein antibody, anti-TNF-alpha, rheumatoid arthritis, TWEAK, SA ANTIBODIES, VIMENTIN, CYTOKINE, BLOCKING, PEPTIDE

Abstract

Objectives: In this study, we evaluated the serum levels of a serum TNF-related weak inducer of apoptosis (TWEAK) and anti-citrullinated protein antibody (ACPA) and investigated the possible correlation of these parameters with disease activity, cytokine levels and anti-TNF-alpha treatment in patients with rheumatoid arthritis (RA).